Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice

Activation of cannabinoid receptor type 2 has been shown to have anti-fibrosis function in skin and heart. However, whether activating cannabinoid receptor type 2 inhibits pulmonary fibrosis remains elusive. Lung fibroblasts and TGF-β1 are key players in the pathogenesis of pulmonary fibrosis. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Qiang, Zheng, Yi, Dong, Xin, Wang, Li, Jiang, Chun Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732744/
https://www.ncbi.nlm.nih.gov/pubmed/29262578
http://dx.doi.org/10.18632/oncotarget.21975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732744/
https://www.ncbi.nlm.nih.gov/pubmed/29262578
http://dx.doi.org/10.18632/oncotarget.21975

Ejemplares similares